PubRank

Helena Rabie

Author PubWeight™ 51.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration. S Afr Med J 2009 2.97
2 Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial. Lancet 2013 2.64
3 Virologic failure and second-line antiretroviral therapy in children in South Africa--the IeDEA Southern Africa collaboration. J Acquir Immune Defic Syndr 2011 2.39
4 Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaboration. S Afr Med J 2009 2.17
5 Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial. BMJ 2006 2.13
6 Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration. J Acquir Immune Defic Syndr 2013 1.82
7 Tuberculosis-associated immune reconstitution inflammatory syndrome and unmasking of tuberculosis by antiretroviral therapy. Clin Chest Med 2009 1.68
8 Clinical presentation and outcome of tuberculosis in human immunodeficiency virus infected children on anti-retroviral therapy. BMC Pediatr 2008 1.49
9 Protease inhibitor resistance in South African children with virologic failure. Pediatr Infect Dis J 2009 1.37
10 Lopinavir exposure is insufficient in children given double doses of lopinavir/ritonavir during rifampicin-based treatment for tuberculosis. Antivir Ther 2011 1.17
11 Opsoclonus-myoclonus in an HIV-infected child on antiretroviral therapy--possible immune reconstitution inflammatory syndrome. Eur J Paediatr Neurol 2005 1.14
12 Virologic response in children treated with abacavir-compared with stavudine-based antiretroviral treatment: a South African multi-cohort analysis. Pediatr Infect Dis J 2014 1.09
13 High prevalence of lipoatrophy in pre-pubertal South African children on antiretroviral therapy: a cross-sectional study. BMC Pediatr 2012 1.08
14 Variability of growth in children starting antiretroviral treatment in southern Africa. Pediatrics 2012 1.08
15 Accuracy of immunological criteria for identifying virological failure in children on antiretroviral therapy - the IeDEA Southern Africa Collaboration. Trop Med Int Health 2011 1.05
16 Detecting tuberculosis infection in HIV-infected children: a study of diagnostic accuracy, confounding and interaction. Pediatr Infect Dis J 2013 1.00
17 It is time to consider third-line options in antiretroviral-experienced paediatric patients? J Int AIDS Soc 2011 0.89
18 When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa. PLoS Med 2013 0.89
19 Poverty and human immunodeficiency virus in children: a view from the Western Cape, South Africa. Ann N Y Acad Sci 2007 0.88
20 Prognosis of children with HIV-1 infection starting antiretroviral therapy in Southern Africa: a collaborative analysis of treatment programs. Pediatr Infect Dis J 2014 0.88
21 Incidence of AIDS-defining and Other Cancers in HIV-positive Children in South Africa: Record Linkage Study. Pediatr Infect Dis J 2016 0.87
22 The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failure. Trop Med Int Health 2012 0.86
23 Nevirapine plasma concentrations in premature infants exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV-1. S Afr Med J 2011 0.85
24 Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort study. J Acquir Immune Defic Syndr 2014 0.85
25 Outcomes of Infants Starting Antiretroviral Therapy in Southern Africa, 2004-2012. J Acquir Immune Defic Syndr 2015 0.82
26 Acute demyelinating encephalomyelitis (ADEM), cryptococcal reactivation and disseminated Herpes simplex in an HIV infected child following HAART. Eur J Paediatr Neurol 2005 0.82
27 Viral load versus CD4⁺ monitoring and 5-year outcomes of antiretroviral therapy in HIV-positive children in Southern Africa: a cohort-based modelling study. AIDS 2014 0.81
28 Reducing CD4 Monitoring in Children on Antiretroviral Therapy With Virologic Suppression. Pediatr Infect Dis J 2015 0.81
29 Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) Study. BMC Res Notes 2011 0.80
30 A retrospective study of cryptosporidial diarrhea in a region with high HIV prevalence. J Trop Pediatr 2010 0.79
31 Infections in HIV-exposed uninfected children with focus on sub-Saharan Africa. Pediatr Infect Dis J 2014 0.78
32 Atypical features of congenital syphilis in an HIV-exposed uninfected neonate. Pediatr Int 2010 0.77
33 Antiretroviral therapy in children with tuberculosis: progress toward defining the issues. J Infect Dis 2010 0.77
34 Oseltamivir use in low-birth weight infants during the 2009 nH1N1 influenza a outbreak in the Western Cape, South Africa. J Trop Pediatr 2011 0.77
35 Fatal hepatitis B infection despite immunization in an HIV-infected infant: a possible case of vaccine failure and immune reconstitution inflammatory syndrome. J Trop Pediatr 2010 0.77
36 Biceps skin-fold thickness may detect and predict early lipoatrophy in HIV-infected children. Pediatr Infect Dis J 2013 0.77
37 Neurological manifestations of TB-IRIS: a report of 4 children. Eur J Paediatr Neurol 2012 0.77
38 Nitazoxanide for severe cryptosporidial diarrhea in human immunodeficiency virus infected children. Pediatr Infect Dis J 2008 0.77
39 Radiology services for children in HIV- and TB-endemic regions: scope for greater collaboration between radiologists and clinicians caring for children. Pediatr Radiol 2009 0.77
40 Minimizing the risk of non-vertical, non-sexual HIV infection in children--beyond mother to child transmission. J Int AIDS Soc 2012 0.76
41 Pseudocystic cryptococcal meningitis complicated by transient periaqueductal obstruction in a child with HIV infection. Eur J Paediatr Neurol 2005 0.76
42 Trough lopinavir concentrations in preterm HIV-infected infants. Pediatr Infect Dis J 2012 0.76
43 Antiretroviral regimens containing a single protease inhibitor increase risk of virologic failure in young HIV-infected children. Pediatr Infect Dis J 2013 0.75
44 Another milestone in minimizing risks to mothers exposed to single-dose nevirapine for prevention of vertical transmission of HIV-1 to infants: what next? Clin Infect Dis 2010 0.75
45 Group B streptococcal disease in infants. Lancet 2012 0.75
46 Growth in Virologically Suppressed HIV-Positive Children on Antiretroviral Therapy: Individual and Population-level References. Pediatr Infect Dis J 2015 0.75
47 Nocardia pneumonia in an HIV-infected neonate presenting as acute necrotising pneumonia. BMJ Case Rep 2013 0.75
48 Impact of earlier combination antiretroviral therapy on outcomes in children. Curr Opin HIV AIDS 2015 0.75
49 UNSUSPECTED FATAL DRUG-RESISTANT TUBERCULOSIS IN A CLOSELY MONITORED CHILD: A PLEA FOR IMPROVED SOURCE-CASE TRACING AND DRUG SUSCEPTIBILITY TESTING. South Afr J Epidemiol Infect 2010 0.75
50 Complicated and protracted cryptococcal disease in HIV-infected children. Pediatr Infect Dis J 2015 0.75
51 Profile of Young South African Children Hospitalized With HIV: Cause for Concern. Pediatr Infect Dis J 2020 0.75
52 Pediatric and adolescent imported malaria in Cape Town. Pediatr Infect Dis J 2009 0.75
53 Presumed cytomegalovirus retinitis in human immunodeficiency virus type I-infected South African children. Pediatr Infect Dis J 2011 0.75
54 Are lopinavir and efavirenz serum concentrations in HIV-infected children in the therapeutic range in clinical practice? Paediatr Int Child Health 2013 0.75
55 Antiretroviral Treatment Initiated in the First Month of Life. Pediatr Infect Dis J 2016 0.75
56 Malaria in children--prevention and management. Infect Disord Drug Targets 2013 0.75
57 Paediatric antiretroviral drug targets. Infect Disord Drug Targets 2011 0.75